GYS2 and intrahepatic cholangiocarcinoma: Subsequently, we detected the expression of GYS2 in matched ICC clinical specimens by qPCR, and found that the GYS2 in ICC was observably down-regulated, which was consistent with the results of the previous bioinformatics analysis.